Department of Pathological Anatomy

Medicine & Life Sciences

1. Adenocarcinoma 10%
2. Ameloblastoma 7%
3. Annona 6%
4. Anti-Inflammatory Agents 7%
5. antimycin 6%
6. Apoptosis 13%
7. Azoxymethane 6%
8. B-Lymphocytes 8%
9. Basal Cell Carcinoma 6%
10. Biomarkers 5%
11. Biopsy 13%
12. Bone and Bones 14%
13. Breast 6%
14. Breast Neoplasms 44%
15. Carcinogenesis 9%
16. Carcinoma 19%
17. Case-Control Studies 7%
18. Caspase 3 13%
19. Catenins 9%
20. Cell Biology 9%
21. Cell Line 14%
22. Cell Proliferation 7%
23. Chitosan 6%
24. Chronic Hepatitis B 6%
25. Colon 15%
26. Colorectal Neoplasms 24%
27. Control Groups 11%
28. Cross-Sectional Studies 7%
29. Curcumin 6%
30. Cyclin D1 7%
31. Cyclooxygenase 2 7%
32. Dextran Sulfate 17%
33. Drug Therapy 14%
34. Ductal Carcinoma 7%
35. Embryonal Rhabdomyosarcoma 6%
36. Endometrioid Carcinoma 6%
37. Eosine Yellowish-(YS) 6%
38. Epidemiologic Studies 6%
39. Ethanol 10%
40. Fibrosis 7%
41. Fruit 6%
42. General Hospitals 7%
43. Genes 8%
44. Giant Cell Tumor of Bone 7%
45. Giant Cell Tumors 6%
46. Growth 6%
47. Hematoxylin 5%
48. Hepatocellular Carcinoma 10%
49. Human Herpesvirus 4 11%
50. Immunohistochemistry 20%
51. In Vitro Techniques 6%
52. Incidence 7%
53. Indonesia 100%
54. Inflammation 9%
55. Japan 11%
56. Keratin-19 7%
57. Liver 11%
58. Lymph Nodes 13%
59. Lymphocytes 6%
60. Lymphoma 14%
61. Lymphoma, Large B-Cell, Diffuse 12%
62. Melanoma 8%
63. Mesenchymal Stem Cells 8%
64. Messenger RNA 5%
65. Mutation 10%
66. Nasopharyngeal Carcinoma 6%
67. Natural Killer Cells 6%
68. Neoplasm Metastasis 20%
69. Neoplasms 43%
70. Neoplastic Stem Cells 6%
71. NF-kappa B 6%
72. nucleolar organizer region associated proteins 5%
73. Osteosarcoma 8%
74. Ovarian Epithelial Carcinoma 6%
75. Paraffin 9%
76. Pathology 9%
77. Pleural Empyema 11%
78. Polyps 7%
79. Pomegranate 6%
80. Population 7%
81. Proteins 12%
82. Recurrence 7%
83. Retrospective Studies 6%
84. Sarcoma 7%
85. Sensitivity and Specificity 6%
86. Skin 6%
87. Skin Neoplasms 14%
88. Sprague Dawley Rats 8%
89. Squamous Cell Carcinoma 17%
90. Staining and Labeling 17%
91. Survival 10%
92. T-Cell Lymphoma 11%
93. T-Lymphocytes 6%
94. Therapeutics 10%
95. Tuberculosis 7%
96. Tumor-Infiltrating Lymphocytes 7%
97. Uterine Cervical Neoplasms 26%
98. Wistar Rats 6%
99. Wound Healing 5%
100. Wounds and Injuries 6%